Stocks hovered around the flat line in midday trading Monday with the Dow and the S&P 500 slightly down and the Nasdaq inching slightly higher. Crude oil also a bit lower at $59.18 a barrel. Shares of drug-maker Actavis (ACT) were rising after the company beat earnings estimates. Actavis reported adjusted quarterly profit of $4.30 a share, topping estimates of $3.93 a share. Revenue also topped expectations, helped by higher sales of its drugs in North America. And in the latest deal spurred by lower oil prices, Rosetta Resources (ROSE) shares were surging after Noble Energy (NBL) said it would acquire the energy company for $2.1 billion in stock. Noble will also assume Rosetta's net debt of $1.8 billion as of March 31.
More from Video
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.
AMSC CEO discusses that and China challenges.
One of pharma's biggest CEO's talks M&A action on the exchange.